You have 9 free searches left this month | for more free features.

Prostate Specific Membrane Antigen

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate-Specific Membrane Antigen PET Scans in People Prostate

Recruiting
  • Prostate Cancer
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 29, 2022

Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

Not yet recruiting
  • Medullary Thyroid Cancer
  • +3 more
  • Groningen, Netherlands
    University Medical Centre Groningen
Sep 8, 2022

Positron Emission Radiomics With PSMA Radioligands on Newly

Not yet recruiting
  • Prostate Cancer
  • Immunohistochemistry (IHC) analysis
  • (no location specified)
Apr 6, 2023

Prostate Cancer Trial in Vienna (PSMA PET Scan, FDHT PET Scan)

Recruiting
  • Prostate Cancer
  • PSMA PET Scan
  • FDHT PET Scan
  • Vienna, Austria
    Medical University of Vienna
Oct 25, 2021

Prostate Cancer Trial in San Francisco (CTT1403, CTT1057, 68Ga-PSMA-11)

Active, not recruiting
  • Prostate Cancer
  • San Francisco, California
    University of California, San Francisco
Apr 14, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11GBq of 177Lu-EB-PSMA-617, 2.00 GBq of 177Lu-EB-PSMA-617,

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • 1.11GBq of 177Lu-EB-PSMA-617
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
May 6, 2022

Prostate Cancer Patients Treated With Lutetium - Prostate

Recruiting
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • WB-MRI
  • Meldola, Forlì-Cesena, Italy
  • +1 more
Jan 12, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer, Stage III Prostate Cancer Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +3 more
  • anti-PSMA monoclonal antibody MDX1201-A488
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • (no location specified)
Mar 28, 2023

Metastatic Prostate Adenocarcinoma Trial in New York (68Ga-PSMA-cyclotron Versus 68Ga-PSMA-generator)

Completed
  • Metastatic Prostate Adenocarcinoma
  • 68Ga-PSMA-cyclotron Versus 68Ga-PSMA-generator
  • New York, New York
    Weill Cornell Medicine
Feb 1, 2022

Thyroid Gland Carcinoma Trial in San Francisco (Gallium Ga 68-labeled PSMA-11, Magnetic Resonance Imaging, Positron Emission

Terminated
  • Thyroid Gland Carcinoma
  • Gallium Ga 68-labeled PSMA-11
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 25, 2021

GBM, Glioblastoma Multiforme, Gliosarcoma Trial in Providence, Dallas (PSMA ADC)

Completed
  • GBM
  • +2 more
  • PSMA ADC
  • Providence, Rhode Island
  • +1 more
Nov 22, 2021

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • MRI-guided Intensity-Modulated Radiation Therapy
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023

68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer

Completed
  • PET/CT
  • +2 more
  • total-body PET/CT
  • Shanghai, Shanghai, China
    Shanghai jiaotong University School of Medicine, Renji Hospital
Nov 15, 2021

Prostate Cancer Trial in Chandigarh (Robotic arm assisted PSMA PET/CT guided prostate biopsy)

Completed
  • Prostate Cancer
  • Robotic arm assisted PSMA PET/CT guided prostate biopsy
  • Chandigarh, Chandīgarh, India
    Department of Nuclear Medicine, PGIMER
Aug 20, 2021

Prostatic Tumors Trial in Worldwide (JNJ-80038114)

Not yet recruiting
  • Prostatic Neoplasms
  • Nashville, Tennessee
  • +8 more
Aug 2, 2022

Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging

Completed
  • Stage II Prostate Adenocarcinoma
  • Stage III Prostate Adenocarcinoma
  • Palo Alto, California
    Stanford University, School of Medicine
Mar 2, 2022

Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)

Suspended
  • Biochemically Recurrent Prostate Carcinoma
  • Gallium Ga 68-labeled PSMA-11
  • Positron Emission Tomography
  • Duarte, California
    City of Hope Medical Center
Oct 12, 2022

Malignant Tumor Trial in Wuhan (68Ga-PSMA, PET/MR, PET/CT)

Recruiting
  • Malignant Neoplasm
  • Wuhan, Hubei, China
    China, Hubei Province
Feb 9, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • San Francisco, California
    University of California San Francisco
Feb 27, 2022

Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial in Kansas City

Not yet recruiting
  • Stage IIC Prostate Cancer AJCC v8
  • +2 more
  • Biospecimen Collection
  • +9 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 3, 2023

Prostate Cancer Trial in Zurich ([68Ga]PSMA-11, [18F]PSMA-1007)

Completed
  • Prostate Cancer
  • Zurich, Switzerland
    University Hospital Zurich
Aug 27, 2021

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta

Not yet recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +2 more
  • Atlanta, Georgia
  • +1 more
Feb 8, 2023

High Risk Prostate Cancer Trial in Turku (Whole body contrast enhanced computer tomography, 99mTC-HMDP planar bone scintigraphy

Completed
  • High Risk Prostate Cancer
  • Whole body contrast enhanced computer tomography
  • +4 more
  • Turku, Finland
    Department of Urology
May 3, 2022